全文获取类型
收费全文 | 1978245篇 |
免费 | 140452篇 |
国内免费 | 3999篇 |
专业分类
耳鼻咽喉 | 28506篇 |
儿科学 | 64951篇 |
妇产科学 | 57576篇 |
基础医学 | 286023篇 |
口腔科学 | 55592篇 |
临床医学 | 168039篇 |
内科学 | 388653篇 |
皮肤病学 | 41712篇 |
神经病学 | 155066篇 |
特种医学 | 78006篇 |
外国民族医学 | 672篇 |
外科学 | 307819篇 |
综合类 | 42249篇 |
现状与发展 | 1篇 |
一般理论 | 525篇 |
预防医学 | 145695篇 |
眼科学 | 45672篇 |
药学 | 147365篇 |
1篇 | |
中国医学 | 3888篇 |
肿瘤学 | 104685篇 |
出版年
2018年 | 18958篇 |
2016年 | 16124篇 |
2015年 | 18457篇 |
2014年 | 26002篇 |
2013年 | 39763篇 |
2012年 | 53955篇 |
2011年 | 57808篇 |
2010年 | 34609篇 |
2009年 | 32700篇 |
2008年 | 55657篇 |
2007年 | 59807篇 |
2006年 | 60713篇 |
2005年 | 59479篇 |
2004年 | 57106篇 |
2003年 | 55446篇 |
2002年 | 54567篇 |
2001年 | 88128篇 |
2000年 | 90556篇 |
1999年 | 77354篇 |
1998年 | 21932篇 |
1997年 | 19822篇 |
1996年 | 19941篇 |
1995年 | 18718篇 |
1994年 | 17821篇 |
1993年 | 16651篇 |
1992年 | 61880篇 |
1991年 | 60481篇 |
1990年 | 59468篇 |
1989年 | 57551篇 |
1988年 | 53743篇 |
1987年 | 52707篇 |
1986年 | 50438篇 |
1985年 | 48151篇 |
1984年 | 36068篇 |
1983年 | 31097篇 |
1982年 | 18688篇 |
1981年 | 16429篇 |
1979年 | 34064篇 |
1978年 | 23949篇 |
1977年 | 20525篇 |
1976年 | 19424篇 |
1975年 | 21362篇 |
1974年 | 25269篇 |
1973年 | 24306篇 |
1972年 | 23128篇 |
1971年 | 21516篇 |
1970年 | 20248篇 |
1969年 | 19218篇 |
1968年 | 18230篇 |
1967年 | 16289篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
van der Heijden Amber A. W. A. de Bruijne Martine C. Nijpels Giel Hugtenburg Jacqueline G. 《International journal of clinical pharmacy》2019,41(4):963-971
International Journal of Clinical Pharmacy - Background Drug-related problems (DRP) following hospital discharge may cause morbidity, mortality and hospital re-admissions. It is unclear whether a... 相似文献
72.
73.
M. Iachina P.M. Ljungdalh R.G. Sørensen L. Kaerlev J. Blaakær O. Trosko N. Qvist B.M. Nørgård 《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(2):115-123
Aims
To examine the influence of pre-existing psychiatric disorder on the choice of treatment in patients with gynaecological cancer.Materials and methods
The analyses were based on all patients who underwent surgical treatment for endometrial, ovarian or cervical cancer who were registered in the Danish Gynecological Cancer Database in the years 2007–2014 (3059 patients with ovarian cancer, 5100 patients with endometrial cancer and 1150 with cervical cancer). Logistic regression model and Cox regression model, adjusted for relevant confounders, were used to estimate the effect of pre-existing psychiatric disorder on the course of cancer treatment. Our outcomes were (i) presurgical oncological treatment, (ii) macroradical surgery for patients with ovarian cancer, (iii) radiation/chemotherapy within 30 days and 100 days after surgery and (iv) time from surgery to first oncological treatment.Results
In the group of patients with ovarian cancer, more patients with a psychiatric disorder received macroradical surgery versus patients without a psychiatric disorder, corresponding to an adjusted odds ratio of 1.24 (95% confidence interval 0.62–2.41) and the chance for having oncological treatment within 100 days was odds ratio = 1.26 (95% confidence interval 0.77–2.10). As for patients with endometrial cancer, all outcome estimates were close to unity. The adjusted odds ratio for oncological treatment within 30 days after surgery in patients with cervical cancer with a history of psychiatric disorder was 0.20 (95% confidence interval 0.03–1.54).Conclusions
We did not find any significant differences in the treatment of ovarian and endometrial cancer in patients with pre-existing psychiatric diagnoses. When it comes to oncological treatment, we suggest that increased attention should be paid to patients with cervical cancer having a pre-existing psychiatric diagnosis. 相似文献74.
75.
Sandrine F. Chebekoue 《Journal of occupational and environmental hygiene》2019,16(4):308-319
This study aimed at deriving occupational thresholds of toxicological concern for inhalation exposure to systemically-acting organic chemicals using predicted internal doses. The latter were also used to evaluate the quantitative relationship between occupational exposure limit and internal dose. Three internal dose measures were identified for investigation: (i) the daily area under the venous blood concentration vs. time curve, (ii) the daily rate of the amount of parent chemical metabolized, and (iii) the maximum venous blood concentration at the end of an 8-hr work shift. A dataset of 276 organic chemicals with 8-hr threshold limit values-time-weighted average was compiled along with their molecular structure and Cramer classes (Class I: low toxicity, Class II: intermediate toxicity, Class III: suggestive of significant toxicity). Using a human physiologically-based pharmacokinetic model, the three identified dose metrics were predicted for an 8-hr occupational inhalation exposure to the threshold limit value for each chemical. Distributional analyses of the predicted dose metrics were performed to identify the percentile values corresponding to the occupational thresholds of toxicological concern. Also, simple linear regression analyses were performed to evaluate the relationship between the 8-hr threshold limit value and each of the predicted dose metrics, respectively. No threshold of toxicological concern could be derived for class II due to few chemicals. Based on the daily rate of the amount of parent chemical metabolized, the proposed internal dose-based occupational thresholds of toxicological concern were 5.61?×?10?2 and 9?×?10?4 mmol/d at the 10th percentile level for classes I and III, respectively, while they were 4.55?×?10?1 and 8.5?×?10?3 mmol/d at the 25th percentile level. Even though high and significant correlations were observed between the 8-hr threshold limit values and the predicted dose metrics, the one with the rate of the amount of chemical metabolized was remarkable regardless of the Cramer class (r2 = 0.81; n = 276). The proposed internal dose-based occupational thresholds of toxicological concern are potentially useful for screening-level assessments as well as prioritization within an integrated occupational risk assessment framework. 相似文献
76.
Katherine M. Duszynski Nicole L. Pratt John W. Lynch Jesia G. Berry Michael S. Gold 《Vaccine》2019,37(2):280-288
Objective
To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.Design
Observational nationwide cohort study.Setting
Linked population data from the Australian Childhood Immunisation Register and National Death Index.Participants
Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.Main outcome measures
Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.Results
The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.Conclusion
Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality. 相似文献77.
78.
79.
80.